Quarterly report pursuant to Section 13 or 15(d)

Share-Based Payments (Tables)

v3.7.0.1
Share-Based Payments (Tables)
 9 Months Ended
Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Restricted Stock Activity
The transactions for restricted stock for the nine months ended June 30, 2017 were as follows:
 
Shares
 
Weighted-
average
grant-date
fair value
Non-vested at September 30, 2016
522,710

 
$
45.10

Granted
216,655

 
66.61

Vested
(186,367
)
 
47.29

Expired or forfeited
(6,950
)
 
50.29

Non-vested at June 30, 2017
546,048

 
$
52.82

Stock Option Activity
The transactions for shares under options for the nine months ended June 30, 2017 were as follows:
 
Shares
 
Weighted-
average
exercise price
 
Weighted-
average
remaining
contractual term
 
Aggregate
intrinsic
value
Outstanding, September 30, 2016
77,733

 
$
40.56

 
 
 
 
Exercised
(333
)
 
40.56

 
 
 
 
Expired or forfeited
(77,400
)
 
40.56

 
 
 
 
Outstanding, June 30, 2017
—

 
—

 
—

 
$
—

Exercisable, June 30, 2017
—

 
$
—

 
—

 
$
—

Non-vested Options Activity
The transactions for non-vested options for the nine-months ended June 30, 2017 were as follows:
 
 
 
Weighted-average
grant-date
 
Shares
 
fair value
Non-vested at September 30, 2016
77,400

 
$
12.29

Expired or forfeited
(77,400
)
 
12.29

Non-vested at June 30, 2017
—

 
$
—

Assumptions used in Estimating Fair Value
The following table indicates the assumptions used in estimating the fair value of restricted stock granted during the nine-month periods ended June 30, 2017 and 2016.
 
Nine Months Ended
June 30,
 
2017
 
2016
Expected volatility
20.2
%
 
20.7
%
Dividend yield
1.1
%
 
1.0
%
Average risk-free interest rate
1.7
%
 
1.7
%
Average expected term (years)
2.1

 
2.1